『DNA Dialogues: Conversations in Genetic Counseling Research』のカバーアート

DNA Dialogues: Conversations in Genetic Counseling Research

DNA Dialogues: Conversations in Genetic Counseling Research

著者： Journal of Genetic Counseling (Jehannine Austin Naomi Wagner Khalida Liaquat Kate Wilson and DNA Today’s Kira Dineen)
無料で聴く

In DNA Dialogues we dive into the intricate world of genetic counseling research. Join us as we peel back the layers of groundbreaking articles from the Journal of Genetic Counseling, bringing you exclusive discussions with the authors themselves. Each episode sparks a vibrant exchange, exploring the latest discoveries, ethical dilemmas, and technological advances that are shaping the future of medical genetics. From navigating complex testing decisions to building trust with diverse communities, listen in as we unpack the science, challenge assumptions, and celebrate the human connection at the heart of genetic counseling research. So, grab your headphones, unravel the double helix, and prepare to be captivated by the array of voices in DNA Dialogues, a podcast where the blueprint of life meets intimate human conversation.Copyright 2026 All Rights Reserved 生物科学 科学
エピソード
  • #33- Huntington’s Disease: Stigma, Genetic Risk and Family Decisions

    #33- Huntington’s Disease: Stigma, Genetic Risk and Family Decisions
    2026/10/29
    This episode focuses on published articles related to Huntington’s disease (HD). In the first segment we discuss how stigma is defined, experienced, and measured in HD research by talking to two researchers who discuss findings from a scoping review examining three decades of literature. For the second segment, we interview two researchers about their study on how individuals and families navigate genetic testing and reproductive decisions when HD runs in the family. Segment 1: Exploring stigma in Huntington's disease: A scoping review of methods and conceptualizations for understanding experiences of gene expansion carriers and at-risk individuals Dr Sarah Gunn is a clinical psychologist and researcher in clinical psychology at the University of Leicester, UK. She is also a member of a family affected by Huntington's disease (HD). Her primary research area is in understanding and formulating the psychological impacts of HD, and developing interventions to improve mental wellbeing among HD families (including people with the gene expansion, their caregivers and wider family members). Sarah is the author of "Coping with Huntington's", a book which combines guidance on mental health strategies and discussion of her personal lived experience of HD, and she currently holds a Wellcome award for an eight-year programme of research into mental health in HD families. Sarah can be found on Instagram @HDinMind. Jane Simpson is Professor of the Psychology of Neurodegenerative Conditions at Lancaster University. As both an academic and clinical psychologist she has been working to improve our understandings of the lives of people affected by conditions such as Huntington’s for over 20 years and has over 160 peer-reviewed publications. She is particularly keen to develop effective interventions to improve mental health, and practitioners’ understandings of mental health. Jane is co-lead of the Psychological Approaches and Interventions working group of the European Huntington’s Disease Network: Psychological Interventions and Approaches WG – European Huntington's Disease Network In this segment we discuss: - Understanding stigma through theoretical frameworks - The lack of a formal theoretical definition of stigma in HD research - Who is represented in the research on stigma in HD - The future of HD stigma research Segment 2: The Recommendation Paradox: Perspectives on Genetic Testing in Huntington's Disease Families Dr. Noit Inbar Parkinson's & Huntington's Disease clinician and researcher Movement Disorders Unit, Tel Aviv Sourasky Medical Center; Physical Therapy Department, Stanley Steyer School of Health Sciences, Tel Aviv University Nurit Omer, MD Deputy Director, Neurology Department Director, HD and CJD Clinic Cognitive Neurology Unit Movement Disorders Unit Neurological Institute Tel-Aviv Medical Center (Ichilov) Tel-Aviv University Tel-Aviv, Israel In this segment we discuss: - What the study team learned about how individuals and families come to understand their risk - The difficult choices faced by people at risk for HD - How experiences differ among people with HD, at-risk relatives, and spouses or partners - Why people may approach genetic testing for themselves differently from reproductive decisions intended to prevent HD transmission to their children. Would you like to nominate a JoGC article to be featured in the show? If so, please fill out this nomination submission form here. Multiple entries are encouraged including articles where you, your colleagues, or your friends are authors. Stay tuned for the next new episode of DNA Dialogues! In the meantime, listen to all our episodes Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Dialogues”. For more information about this episode visit dnadialogues.podbean.com, where you can also stream all episodes of the show. Check out the Journal of Genetic Counseling here for articles featured in this episode and others. Any questions, episode ideas, guest pitches, or comments can be sent into DNADialoguesPodcast@gmail.com. DNA Dialogues’ team includes Jehannine Austin, Naomi Wagner, Khalida Liaquat, Kate Wilson and DNA Today’s Kira Dineen. Our logo was designed by Ashlyn Enokian. Our current intern is Vanaja Chavva.
    続きを読む 一部表示
    1 時間
  • #32- Exploring new approaches to service delivery: video tools and consumer experiences

    #32- Exploring new approaches to service delivery: video tools and consumer experiences
    2026/10/01
    This episode explores genetic service delivery and various ways genetic counseling can be incorporated. Segment 1: How to Reduce Time to Genetic Testing: A Video-Based Approach in the Inherited Cardiac Conditions Service Guest Bios Dr Lisa Bryson is a Clinical Genetics Registrar at the Centre for Genomic Medicine in Glasgow, with a background in paediatrics. She is due to complete her clinical genetics training shortly and will take up a Consultant Clinical Geneticist post in New Zealand. She has been involved in a number of research projects alongside her clinical training, including the GenVid pilot study and as an Associate Principal Investigator for the GENROC study. Her research interests include rare disease and the clinical application of genomic medicine. Dr Ruth McGowan is a Consultant in Clinical Genetics (West of Scotland, Centre for Genomic Medicine), Honorary Clinical Associate Professor (University of Glasgow) and member of the Developmental Endocrinology Research Group (DERG), affiliated to University of Glasgow. Her key interests are Inherited Cardiac Conditions, Rare Conditions and Disorders of Sex Development. She is an active member of the Network for Inherited Cardiac Conditions Scotland (NICCS) and was previously Co-chair of the Scottish Rare Disease Implementation Board. Dr Ruth McGowan is the Lead Clinical Geneticist for the West of Scotland Inherited Cardiac Conditions service. She has been Chief or Principal Investigator of numerous research projects including the MRC/CSO funded ‘Scottish Genomes Partnership’, the ‘Scottish Participation in the 100K Genomes Knowledgebase’ and the ‘Genetic Investigation of Rare Disorders’ study. In this segment we discuss: - Use of a video-based genetic counseling pathway in the UK NHS for patients at risk of an inherited cardiac conditions - The impact of GenVid pathway on barriers to genetic services - Integration of genetic counseling and digital tools Segment 2: Consumer Experiences and Perceptions of Genetic Counseling in Provider-Mediated Genetic Testing Guest Bios: Madison Kilbride, PhD, is an Assistant Professor of Philosophy at the University of Utah. She received her doctorate from Princeton University and was a fellow in the Postdoctoral Training Program in the Ethical, Legal and Social Implications (ELSI) of Genetics and Genomics at the University of Pennsylvania. Her scholarship examines ethical issues surrounding genetic testing, particularly those raised by consumer genetic testing. Katie Lauro, MS, LCGC is a general genetics and cancer genetic counselor at Genome Medical, a telehealth genetic counseling service. She received her BS in Human Biology from Michigan State University and her MS in Genetic Counseling from the University of Utah Graduate Program in Genetic Counseling (UUGPGC). Katie is grateful for the opportunity to share and discuss her research during her time in the UUGPGC, which was published in the Journal of Genetic Counseling in July 2026. In this segment we discuss: - Provider-mediated genetic testing and its distinction from traditional DTC testing. - The ENLITE study and its focus on consumer experiences with genetic testing - Consumer perceptions of genetic counseling and barriers to access - Future directions for integrating genetic counseling into broader healthcare settings Would you like to nominate a JoGC article to be featured in the show? If so, please fill out this nomination submission form here. Multiple entries are encouraged including articles where you, your colleagues, or your friends are authors. Stay tuned for the next new episode of DNA Dialogues! In the meantime, listen to all our episodes Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Dialogues”. For more information about this episode visit dnadialogues.podbean.com, where you can also stream all episodes of the show. Check out the Journal of Genetic Counseling here for articles featured in this episode and others. Any questions, episode ideas, guest pitches, or comments can be sent into DNADialoguesPodcast@gmail.com. DNA Dialogues’ team includes Jehannine Austin, Naomi Wagner, Khalida Liaquat, Kate Wilson and DNA Today’s Kira Dineen. Our logo was designed by Ashlyn Enokian. Our current intern is Vanaja Chavva.
    続きを読む 一部表示
    57 分
  • #31-Trust & Timing: Parental Decisions About Secondary Findings

    #31-Trust & Timing: Parental Decisions About Secondary Findings
    2026/08/27

    Understanding the decision of parents to opt-out of medically actionable secondary findings offered through genome sequencing

    Guest Bios:

    Robin Hayeems is a Senior Scientist in Child Health Evaluative Sciences (CHES) at The Hospital for Sick Children (SickKids) and an Associate Professor in the Institute of Health Policy, Management and Evaluation (IHPME) at the University of Toronto. She is trained in genetic counselling public health and bioethics, health policy research, and health services research.. Her research focuses on the development, implementation, and evaluation of genomic screening and diagnostic tools for the maternal-child health context. As a member of several provincial advisory committees, her work informs and is informed by policy development in this area.

    Abby Hansen is a Master of Science in Genetic Counselling student at the University of British Columbia and a Clinical Research Project Assistant at The Hospital for Sick Children (SickKids). Her research focuses on exploring patient experiences with genetic testing and the factors that shape genetic testing-related decision-making. Drawing on both her research experience and clinical training, Abby is passionate about providing compassionate, patient-centred care, and supporting individuals and families in understanding complex genetic information and making informed healthcare decisions.

    In this episode we discuss:

    - Exploring the unexpectedly high opt-out rate for medically actionable secondary findings in Genome-Wide Sequencing Ontario (GSO) and how Canadian guidance surrounding non-diagnostic results differs from U.S. standards.

    - Unpacking how the emotional workload of managing acute medical crises leads some parents to decline secondary findings to avoid living under a "cloud of worry," balancing proactive healthcare with current family peace of mind.

    - Challenges around pediatric autonomy, parental consent misunderstandings regarding data re-analysis, and the clinical case for flexible, two-step disclosure models.

    - Educational tools, scripts, and capacity-building strategies designed to improve genomic literacy among non-genetics providers as genome sequencing expands into mainstream care

    Resources

    - Genome Sequencing Ontario URL website

    Would you like to nominate a JoGC article to be featured in the show? If so, please fill out this nomination submission form here. Multiple entries are encouraged including articles where you, your colleagues, or your friends are authors.

    Stay tuned for the next new episode of DNA Dialogues! In the meantime, listen to all our episodes Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Dialogues”.

    For more information about this episode visit dnadialogues.podbean.com, where you can also stream all episodes of the show. Check out the Journal of Genetic Counseling here for articles featured in this episode and others.

    Any questions, episode ideas, guest pitches, or comments can be sent into DNADialoguesPodcast@gmail.com.

    DNA Dialogues’ team includes Jehannine Austin, Naomi Wagner, Khalida Liaquat, Kate Wilson and DNA Today’s Kira Dineen. Our logo was designed by Ashlyn Enokian. Our current intern is Vanaja Chavva.
    続きを読む 一部表示
    22 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません